Calypso Biotech BV
🇳🇱Netherlands
Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Dose Escalation Study to Evaluate an Experimental New Treatment (CALY-002) in Healthy Subjects and Subjects With Celiac Disease and Eosinophilic Esophagitis
Phase 1
Completed
- Conditions
- Eosinophilic EsophagitisCeliac Disease
- First Posted Date
- 2020-10-19
- Last Posted Date
- 2024-04-09
- Lead Sponsor
- Calypso Biotech BV
- Target Recruit Count
- 73
- Registration Number
- NCT04593251
- Locations
- 🇧🇪
Cliniques Universitaires Saint-Luc - Hospital, Brussel, Belgium
🇧🇪UZ Leuven, Leuven, Belgium
🇫🇮Tampere University Hospital, Tampere, Finland
News
No news found